Glycemic Management

A cohort of adults with type 1 diabetes in Spain had a decrease in mean glucose during the country’s COVID-19 lockdown, with about 17% of the group having clinically meaningful glycemic improvement, according to study data.

Adults with type 2 diabetes who improved blood glucose during an intensive lifestyle intervention saw improvements in cognitive test scores after a decade of follow-up, according to a study.

Intensive blood sugar control in patients with diabetes may lead to an increased initial rate of diabetic retinopathy over a 90-day period.

Researchers found that bempedoic acid significantly reduced LDL compared with placebo in patients with diabetes, prediabetes or normoglycemia and hypercholesterolemia.

Clinicians must adapt protocols for optimal inpatient glycemic management during the COVID-19 pandemic as part of an effort to incorporate new therapies, limit direct patient contact and minimize infection risk, researchers wrote.

Adults with type 2 diabetes who decide not to take insulin are less likely to reduce their HbA1c below 7% over 12 months than those who initiate insulin when recommended, according to findings published in Diabetic Medicine.

CV outcomes in high-risk patients with diabetes receiving statin therapy were strongly associated with baseline HbA1c levels, according to findings published in the Journal of the American Heart Association.